All In Biotech

Drug Trial Radar · NCT07060989

A Study of Safety, Tolerability and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

A Phase 1/2a Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of NTS071 in Subjects With Advanced Solid Tumors Harboring a TP53 Y220C Mutation

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

220

Planned (sponsor's estimate)

Start

Aug 4, 2025

Primary completion

Dec 2028

Study completion Dec 2029

Sponsor

Sponsor type
Industry
First posted
Jul 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to evaluate the safety, tolerability, PK, and preliminary efficacy of NTS071 in adults with TP53 Y220C-mutated solid tumors.

Conditions

  • Advanced Solid Tumors

Interventions

  • NTS071Drug

    Oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Phase 1: Number of dose-limiting toxicity (DLT)Time frame: The first 26 days of treatment (Cycle 1) per patient
  2. Phase 1: incidence of adverse events (AE), serious adverse events (SAEs)Time frame: up to 30 days after the last administration
  3. Phase 2a: Overall Response Rate (ORR)Time frame: Up to 3 years

Locations

10 sites in 2 countries. Site status is shown where the registry gives one.

  • Yale Cancer Center

    New Haven, Connecticut · Recruiting

  • University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • NEXT Virginia

    Fairfax, Virginia · Recruiting

  • Peking University People's Hospital

    Beijing, China · Recruiting

  • Beijing Cancer Hospital

    Beijing, China · Recruiting

  • Guangdong Provincial People's Hospital

    Guangzhou, China · Not yet recruiting

  • The First Affiliated Hospital of Nanchang University - Xianghu District

    Nanchang, China · Recruiting

  • Fudan University Shanghai Cancer Center

    Shanghai, China · Recruiting

  • Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, China · Recruiting

  • The First Affiliated Hospital of Xi'an Jiaotong University

    Xi'an, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.